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Abstract 
Background: Environmentally induced epigenetic changes can lead to health problems or disease, but the mecha‑
nisms involved remain unclear. Morphine can pass through the placental barrier leading to abnormal embryo devel‑
opment. However, the mechanism by which morphine causes these effects and how they sometimes persist into 
adulthood is not well known. To unravel the morphine‑induced chromatin alterations involved in aberrant embryo 
development, we explored the role of the H3K27me3/PRC2 repressive complex in gene expression and its transmis‑
sion across cellular generations in response to morphine.
Results: Using mouse embryonic stem cells as a model system, we found that chronic morphine treatment induces 
a global downregulation of the histone modification H3K27me3. Conversely, ChIP‑Seq showed a remarkable increase 
in H3K27me3 levels at specific genomic sites, particularly promoters, disrupting selective target genes related to 
embryo development, cell cycle and metabolism. Through a self‑regulatory mechanism, morphine downregulated 
the transcription of PRC2 components responsible for H3K27me3 by enriching high H3K27me3 levels at the promoter 
region. Downregulation of PRC2 components persisted for at least 48 h (4 cell cycles) following morphine removal, 
though promoter H3K27me3 levels returned to control levels.
Conclusions: Morphine induces targeting of the PRC2 complex to selected promoters, including those of PRC2 
components, leading to characteristic changes in gene expression and a global reduction in H3K27me3. Following 
morphine removal, enhanced promoter H3K27me3 levels revert to normal sooner than global H3K27me3 or PRC2 
component transcript levels. We suggest that H3K27me3 is involved in initiating morphine‑induced changes in gene 
expression, but not in their maintenance.
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Background
One of the current challenges of biomedicine is to under-
stand how our lifestyle can influence our health and the 
health of future generations. Although some epigenetic 
changes are essential for normal development and age-
ing, there is still limited understanding of how environ-
mental factors can cause epigenetic changes that lead to 
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health problems or diseases such as autoimmune disor-
ders, neurodevelopmental syndromes, cardiovascular 
disease and the majority of tumours [1, 2]. In fact, prena-
tal developmental processes are highly sensitive to toxic 
chemicals and stress, indicating that environmental fac-
tors might cause disturbances in embryo development as 
well as organ malfunction after birth [3]. Previous studies 
have shown that morphine can easily pass through the 
placental barrier and reach the embryo [4, 5]. Morphine 
is a powerful analgesic that acts on membrane-bound 
 Gi-protein coupled opioid receptors, which are widely 
distributed throughout the organism. The therapeu-
tic value of morphine and other opioids for pain relief 
and analgesia is well-established, despite a considerable 
number of adverse physiological side-effects [6]. Mor-
phine has been reported to reduce the weight of differ-
ent organs, such as brain, kidney and liver, as well as the 
head–tail length in rat embryos [7] and promote delays 
in nervous system development [8]. Moreover, in-utero 
morphine exposure has shown alterations in anxiety-like 
behaviours, analgesic tolerance, synaptic plasticity and 
the neuronal structure of offspring [9, 10]. However, the 
mechanism by which morphine impacts the embryo is 
not well known.
Polycomb repressive complex 2 (PRC2) primarily tri-
methylates H3K27, conferring a mark of transcription-
ally silent chromatin at developmental genes during 
embryo development. In mammals, PRC2 is composed 
of 4 core protein subunits, including the enzymatic subu-
nit EZH2 and the following three non-catalytic subunits: 
EED, RBBP4/RBBP7 and SUZ12 proteins [11, 12]. The 
EZH2 component catalyses progressive mono-, di- and 
tri-methylation of H3K27 through its SET domain. In 
contrast, EED and SUZ12 do not have a catalytic func-
tions but are essential for the stabilization of enzymatic 
activity, nucleosome binding and target gene recruitment 
[13, 14]. PRC2 proteins are evolutionarily conserved 
epigenetic regulators, and the complex is required for 
maintaining transcriptional patterns by repressing key 
developmental genes. The critical role of PRC2 proteins 
during development is highlighted by the early embry-
onic lethality observed upon deletion of the Ezh2, Eed, 
Suz12, Ring1b and Rbbp4 genes in mice [15–17]; these 
proteins also play a critical role in the maintenance of cel-
lular memory once cell fates are determined. Intriguingly, 
H3K27me3 and several other histone marks are also 
found in human and mouse sperm, preferentially near 
developmental genes [18–20], raising an interesting ques-
tion as to whether these histone modifications are not 
only involved in cell-to-cell inheritance during embryo 
development but can also be passed on to the next gener-
ation. Considering that the H3K27me3/PRC2 complex is 
a key epigenetic factor crucial for embryo development, 
our aim is to elucidate the role of this repressive complex 
in gene expression and its transmission across cellular 
generations in response to morphine.
Results
Effect of chronic morphine treatment on H3K27me3 
in mESCs
We first sought to determine the global changes induced 
by chronic  morphine treatment in mESCs in  vitro. 
mESCs expressing GFP protein under the Oct4 pro-
moter were treated with morphine (24  h, 10  µM [21]), 
and global levels of the histone modification H3K27me3 
were evaluated by immunoblotting. Although we did 
not observe any morphological changes (Fig.  1a), mor-
phine treatment led to a downregulation of H3K27me3 
levels (Fig. 1b and Additional file 1: Figure S1). Next, we 
studied in more depth the genome-wide distribution of 
Fig. 1 Effect of chronic morphine treatment on H3K27me3 in mESCs. a Scheme of mESCs culture and 24 h morphine treatment for in vitro 
epigenetic changes determination. Representative image of treated and untreated mESCs is also shown. Scale bar = 400 µm. b Western blot 
analysis of H3K27me3 after morphine treatment for 24 h. β‑actin was used as loading control. Sample size n = 5
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H3K27me3 epigenetic marks by chromatin immuno-
precipitation followed by high-throughput sequenc-
ing analysis (ChIP-Seq). Specifically, 8065 binding sites 
(BSs) were annotated in the control sample, while 6899 
BSs were identified after morphine treatment (Fig.  2a). 
Thus, morphine led to a decrease in the number of his-
tone BSs, which was consistent with the global downreg-
ulation of H3K27me3 induced by morphine. Morphine 
caused more significant downregulation of H3K27me3 
BSs at distal intergenic regions and introns (Additional 
file  1: Figure  S2A). Remarkably, morphine produced an 
increase in H3K27me3 enrichment at promoters (Fig. 2b, 
c and Additional file 1: Figure S2A). The distribution plot 
of BSs around transcription start sites (TSSs; ± 3000 bp) 
of the nearest genes (Fig.  2c) confirmed the increase in 
H3K27me3 enrichment around TSS regions in mor-
phine-treated mESCs. The control sample displayed a 
common feature of a TSS-centred plot, with a sharp 
dip in H3K27me3 around the TSS, while the morphine-
treated sample resulted in a single peak showing an 
increase in H3K27me3 enrichment. Because CpG islands 
(CGIs) have been implicated in polycomb recruitment 
and therefore in H3K27me3 modification [22, 23], we 
also analysed the changes induced by morphine at CGIs 
and flanking features (Fig.  2d). CGIs and shore regions 
were enriched after morphine treatment, while enrich-
ment at open sea regions was decreased. Interestingly, we 
observed a remarkable increase at promoter regions with 
high CGI densities.
Considering the differentially enriched regions with 
p < 0.05 and FDR < 0.05, 1028 differential binding sites 
(DBSs) were identified, including 595 upregulated his-
tone sites after morphine treatment and 433 downregu-
lated sites (Additional file 1: Figure S2B, C). Specifically, 
most DBSs sensitive to chronic  morphine treatment 
(63%) were found at promoter regions with a high den-
sity of CGIs (Fig. 2d, e). Heatmap analysis confirmed the 
presence of both up- and downregulated DBSs at the 
different genomic features surrounding CGIs, such as 
shores, shelfs and open sea regions (Fig. 2e).
To understand the biological functions in which mor-
phine was involved, Gene Ontology (GO) analysis was 
performed using The Gene Ontology Resource from the 
GO Consortium (https ://geneo ntolo gy.org/). Functional 
enrichment analysis showed that H3K27me3-enriched 
genes sensitive to morphine were involved in behaviour, 
cognition, embryo development, metabolism and gene 
expression (Fig. 2f and Additional file 1: Figure S3).
Effect of chronic morphine treatment on the global 
transcriptome in mESCs by mRNA‑Sequencing
Due to the impact of histone modifications on gene 
expression, our previous observations prompted us to 
identify specific transcriptome changes associated with 
morphine treatment. Thus, we set out to perform global 
gene expression profiling by RNA-Seq comparing cells 
treated and untreated with morphine for 24 h. Consider-
ing the significant differences with p < 0.05 and FDR < 0.05 
(Fig.  3a), a total of 932 differentially expressed genes 
(DEGs) were identified after 24 h of morphine treatment, 
including 386 upregulated genes and 546 downregulated 
genes. Functional enrichment analysis revealed a role for 
morphine in several biological functions related to female 
gamete generation, nuclear and cell division, DNA repair, 
chromosome organization, gene expression, metabolism 
and signalling (Fig. 3b).
Aiming to understand the relevance of H3K27me3 
chromatin distribution on transcriptomic deregulation 
after chronic  morphine treatment, an integrative analy-
sis was performed between the ChIP-Seq and RNA-
Seq data. We identified 16 genes involved in embryonic 
development, metabolism and chromatin regulation 
whose gene expression deregulation was associated with 
the distribution of H3K27me3 marks at their promoters 
(Additional file  1: Figure  S4C). Remarkably, the expres-
sion of the PRC2 subunit gene Suz12 was downregulated 
and associated with increased H3K27me3 at its pro-
moter. In spite of that, a total of 125 genes sensitive to 
morphine between the transcriptomic and ChIP-Seq 
analyses were identified (Additional file  1: Figure  S4). 
Functional enrichment analysis showed genes related to 
apoptosis, neurogenesis, metabolic processes and gene 
expression changes for both the H3K27me3 distribution 
and gene expression after morphine treatment (Fig. 3b). 
Fig. 2 ChIP‑Sequencing binding distribution of H3K27me3 after chronic morphine treatment. a ChIP‑Sequencing binding distribution of 
H3K27me3 after morphine treatment. Total number of peaks in control and morphine treated samples and Venn diagram of H3K27me3 BSs. b 
Representation of H3K27me3 peaks at ± 3 kb around the TSSs in control and morphine treated samples. c Distribution of the H3K27me3 peaks 
around ± 3 kb from TSS regions. d Pie‑chart showing CpG feature distribution of H3K27me3 peaks in CpG island (belonging to promoter or 
non‑promoter region + 1 kb from TSS), shore (< 2 kb), shelf (< 4 kb) and open sea (the rest of the genome) regions. e Heatmap representation of 
Log2 (FC) values of DBSs in control and treated samples related to promoters CpG island, shore, shelf and open sea regions. f Functional enrichment 
analysis showing the most indicative biological functions of the specific genes annotated from binding sites (BSs) and differential binding sites 
(DBSs). Statistical analyses Bonferroni corrected for p < 0.05
(See figure on next page.)
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Fig. 3 Transcriptomic analysis by RNA‑Seq after chronic morphine treatment in mESCs. a Volcano plot of DEGs showing significant genes (p < 0.05 
and FDR < 0.05) in purple and not significant in grey. b Gene Ontology analysis showing the top biological functions, performed with the criteria 
of Bonferroni corrected for p < 0.05. c Numbers of annotated genes form H3K27me3 binding sites (BSs) and differential binding sites (DBSs), and 
differential expressed genes (DEGs) after 24 h morphine treatment. d Venn diagram showing the overlap between H3K27me3 BSs and DBSs at 
propotor level, and RNA‑seq DEGs after morphine treatment, e Gene Ontology analysis showing the top biological functions, performed with the 
criteria of Bonferroni corrected for p < 0.05
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Considering only those genes that showed H3K27me3 
changes at the promoter level for integrative analyses 
(Fig. 3c), we identified 62 genes related to embryo devel-
opment and cell differentiation as well as apoptosis, 
metabolism and basic cellular processes (Fig. 3d, e), sug-
gesting that the role of H3K27me3 in response to mor-
phine treatment goes beyond gene expression regulation 
alone.
Effect of chronic morphine treatment on PRC2
Morphine led to an increase in H3K27me3 enrichment 
at the Suz12 gene promoter that was consistent with its 
reduced expression (Fig.  4).Therefore, RNA-Seq and 
ChIP-Seq approaches confirmed that morphine was able 
to regulate the PRC2 complex in mESCs. Further analy-
sis (landscape in the UCSC genome browser) showed 
an effect of chronic  morphine treatment not only on 
Suz12 but also on other PRC2 components such as Ezh2, 
Eed, Rbbp4 and Rbbp7 (Fig. 4). Morphine increased the 
H3K27me3 enrichment at promoters, which also corre-
sponds to CGI regions in the core members of the PRC2 
complex. Consistent with the H3K27me3 chromatin dis-
tribution, the RNA-Seq tracks also showed downregula-
tion of all the mentioned PRC2 subunits.
To evaluate whether morphine can induce cellular epi-
genetic memory, we next analysed the dynamic epigenetic 
changes over time in the absence of morphine. For that 
purpose, OCT4-reported mESCs were treated with mor-
phine for 24 h (P1). After morphine removal, the mESCs 
were seeded and maintained in culture for 48  h (P2). 
Since mESCs need to be seeded every two days to main-
tain stemness and prevent cell differentiation, the cells 
were seeded again and maintained in culture for another 
48  h (P3) (Fig.  5a). Morphine did not induce any mor-
phological changes over the three time points (Fig.  5a). 
Immunoblotting analyses showed that morphine induced 
a reduction in H3K27me3 levels at P1. This global reduc-
tion persisted in the absence of morphine through P2 
(48  h), but not to P3 (96  h), in which a slight increase 
was observed (Fig. 5b, c and Additional file 1: Figure S5). 
We then sought to evaluate how morphine modified the 
expression of core PRC2 complex genes over the same 
time course. The expression of Suz12, Eed and the com-
plex catalytic subunit Ezh2 was strongly reduced imme-
diately after 24 h of morphine treatment (P1). For Ezh2 
and Eed, a significant reduction persisted for 48 h in the 
absence of morphine (P2), but the expression of all three 
genes returned to control levels or above by 96  h (P3) 
(Fig.  5c). We next asked if morphine-induced expres-
sion changes could be due to changes in the H3K27me3 
distribution at the promoter level. ChIP-qPCR analyses 
showed a dramatic enrichment of H3K27me3 at the pro-
moters of all three genes over the control immediately 
after 24 h of morphine treatment (P1). However, the lev-
els progressively returned to the control levels after 48 h 
(P2) and were below the control levels by 96 h (P3) in the 
absence of morphine (Fig. 5d).
Discussion
Morphine is known to impact normal embryo develop-
ment by affecting the neural tube, frontal cortex and spi-
nal cord development, and, as a consequence, delaying 
nervous system development [8]. Although morphine can 
easily pass through the placental barrier and reach the 
embryo [4, 5], there is a critical gap in our understand-
ing of how morphine leads to abnormal neurogenesis and 
other physiological consequences during embryo devel-
opment. For the first time, our results provide insights 
into how the H3K27me/PRC2 repressive complex might 
be an important epigenetic mechanism to understand the 
impact of morphine on early embryo development and 
particularly on nervous system development.
Embryonic stem cells are widely used to unravel 
the impacts of environmental stimuli on develop-
mental biology because of their ability to indefinitely 
self-renew and differentiate into any type of cell [24]. 
Similar to other addictive drugs such as alcohol and Δ9-
tetrahydrocannabinol (THC) [25, 26], our results reveal 
that morphine treatment leads to a global downregu-
lation of H3K27me3, which might be mediated throw 
the activation of opioid receptors since they have been 
described in mESC [27, 28]. H3K27me3 represents at 
least 10% of genome-wide genes in mESCs and can main-
tain the silencing of key developmental genes [29]. This 
is consistent with the fact that morphine modifies the 
distribution of H3K27me3 at genes involved in embryo 
development, behaviour, cognition, metabolism and 
gene expression, suggesting that morphine might impact 
H3K27me3 repression at developmental genes. Whole 
genome analyses show this decrease in H3K27me3 bind-
ing sites at different genome features, such as introns and 
intergenic regions. Relatively weak but broad enrichment 
of H3K27me3 has been described outside of CGIs and 
promoters, often spanning gene-dense regions and inter-
genic regions and forming a repressive microenviron-
ment within otherwise active chromatin compartments 
[30, 31]. Consistent with the fact that morphine leads to a 
decrease in global DNA methylation [32, 33], our results 
indicate that morphine may be able to inactivate repres-
sive microenvironments and promote active chromatin 
regions in mESCs.
Despite the whole-genome decrease, chronic morphine 
treatment surprisingly triggers a broad H3K27me3 peak 
around the TSS region of genes, similar to the pattern 
of H3K4me3 [34]. This broad peak is the opposite of the 
sharp dip expected for H3K27me3 [35], highlighting the 
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Fig. 4 Effect of chronic morphine treatment on PRC2 repressive epigenetic complex. RNA‑seq and H3K27me3 ChIP‑seq track transitions enriched 
at promoter level, for PRC2 complex subunits Suz12, Ezh2, Eed, Rbbp4 and Rbbp7. CpG features track was composed by CpG islands in green, shores 
in light blue, shelfs in dark blue and open sea in grey. Red boxes point out the enrichment and gene expression change location
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increase reported at the promoter region. In mammals, 
H3K27me3 is strongly enriched at developmental gene 
promoters [36] by recruiting PcG proteins to DNA hypo-
methylated CGIs through factors such as KDM2B [37]. 
Consistent with this fact, morphine mainly increases 
H3K27me3 levels at promoters with high CGI densi-
ties. In untreated mESCs, H3K27me3 enrichment is 
weighted heavily towards genes involved in developmen-
tal and morphological processes, particularly nervous 
system development. Genes downregulated by morphine 
show partially elevated H3K27me3 at their promoters. 
Morphine disrupts this, at least in part by reducing the 
expression of chromosome organization, metabolism and 
developmental/nervous system genes, which is consistent 
with wide in  vivo evidence [8, 38–40]. As an epigenetic 
regulator, H3K27me3 is directly involved in suppressing 
gene transcription during the embryonic development 
process, where regular epigenetic changes are essen-
tial for cellular differentiation [41–44], and it is tightly 
implicated in neurodegeneration, synaptic function and 
behaviour [45, 46]. Although our results suggest that 
chromatin epigenetic regulation led by H3K27me3 might 
mediate the genomic response to morphine, the role of 
H3K27me3 is more complex and nuanced than has been 
thought since morphine impacts the H3K27me3 chro-
matin distribution of key genes important for apoptosis, 
development and metabolism beyond the regulation of 
their gene expression.
Fig. 5 Epigenetic memory determination in mESC culture in vitro. a Schematic representation of experimental approach to study the cell‑to 
cell epigenetic memory induced by morphine. Epigenetic changes were measured at 24 h after chronic morphine treatment (P1), and 
morphine‑induced epigenetic memory was evaluated at 48 h (P2) and 96 h (P3) after treatment withdrawal. Representative image of treated and 
untreated mESCs is also shown in the studied time points. Scale bar = 400 µm. b In vitro dynamic changes of H3K27me3 histone modification 
induced by 24 h morphine treatment for P1, P2 and P3 after morphine treatment withdrawal in mESCs. β‑actin was used as loading control. Sample 
size n = 5. b Quantification of H3K27me3 levels measured by Image J software.. Statistical significance was determined by Student‑T test (*p < 0.05; 
**p < 0.01; ***p < 0.001), c RT‑qPCR analysis for the validation of PRC2 complex subunits expression, Suz12, Ezh2 and Eed were validated at mRNA 
level (left) and ChIP enrichment level (right). Gapdh and Pcx were used as housekeeping genes for mRNA level analysis and acquired Ct values 
were normalized respect to the control sample using  2ddCT. d ChIP‑RT‑qPCR amplification was normalized respect to the 10% of the input sample. 
Statistical significance was determined by Student‑T test (*p < 0.05; **p < 0.01; ***p < 0.001). Sample size n = 5
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Downregulation of genes encoding core PRC2 compo-
nents may explain the global loss of H3K27me3 induced 
by morphine. PRC2 is composed of 4 core protein sub-
units that function as a holoenzyme [11, 12]. All of the 
subunits are required for proper activity, and an addi-
tive contribution of each component is reported [11]. 
Specifically, morphine leads to transcriptional targeted 
downregulation of the 4 key components of the PRC2 
repressive complex, Suz12, Ezh2, Eed and Rbbp4, along 
with an increase in H3K27me3 enrichment at the pro-
moter. SUZ12 is crucial for interacting with the core 
catalytic subunit EZH2 and EED and binds to CGIs inde-
pendent of the other core subunits [47]. Therefore, mor-
phine may induce global H3K27me3 downregulation by 
both disrupting PRC2 complex recruitment to genomic 
loci and altering its catalytic activity in mESCs [47]. It 
is well established that the repressive PRC2/H3K27me3 
complex is involved in processes such as embryonic 
development [41, 43, 44, 48]. The deletion of PRC2 com-
ponents in somatic cells leads to a marked reduction in 
cell proliferation [49–51] and induces important develop-
mental defects during embryogenesis or tumorigenesis. 
Through a self-regulatory mechanism that involves inhi-
bition of the PRC2 repressive machinery, morphine pro-
motes an aberrant transcriptome in mESCs, which may 
contribute to abnormal embryo development [50, 52, 53].
The ability of chromatin to undergo either dynamic or 
stable changes in response to morphine or other environ-
mental factors can be considered a mechanism for cel-
lular memory [54]. Thus, only those epigenetic changes 
that persist in a stable manner in differentiated cells 
might produce phenotypic changes. However, few studies 
have reported effects on chromatin dynamics after mor-
phine exposure [55], and all of these studies have been 
performed using continuous treatment. Taking a step 
beyond, we proved that mESCs can memorize morphine 
exposure and maintain reduced levels of H3K27me3 for a 
minimum of 4 cell cycles. Considering that mESCs have 
a cell cycle length of approximately 11–14  h [56], mor-
phine reduces H3K27me3 levels that persist at least 48 h 
after treatment removal before recovering to control 
values. In line with this, transcriptional downregulation 
of some PRC2 components also persists for 48 h, which 
implies 4 cell cycles, but not 96 h. While elevated levels of 
promoter H3K27me3 may well be involved in the initial 
morphine-induced downregulation of PRC2 genes in the 
short term, it does not seem necessary for the persistence 
of this effect through multiple cell divisions. These results 
are consistent with the fact that the PRC2/H3K27me3 
mark is involved in the initial steps of stable epigenetic 
processes such as gene imprinting and X-chromosome 
inactivation but not in the maintenance of those repres-
sive marks across cell generations [43], suggesting that 
other epigenetic mechanisms might be involved in the 
maintenance of stable epigenetic changes in response to 
morphine over longer times.
To summarize, our results provide insights into how 
transcriptional changes induced by morphine may be 
mediated by H3K27me3. Morphine disrupts selective 
target genes related to embryo development, particularly 
to nervous system development, cell cycle and metabo-
lism through alterations in H3K27me3 chromatin organi-
zation. Using a self-regulatory mechanism that involves 
the inhibition of PRC2, chronic  morphine treatment 
causes in  vitro global changes in H3K27me3 levels that 
persist in the short term, indicating that this repressive 
complex might be important for the initial phases of cell-
to-cell morphine-induced memory. Further experiments 
are needed to understand the mechanisms underlying 
morphine-induced heritable effects, which will be crucial 
for establishing the foundations of cellular memory in 
response to external stimuli during embryo development.
Methods
Cell culture and treatment
Mouse (Oct4-GFP) embryonic stem cells (mESCs) 
(PCEMM08, PrimCells) were cultured feeder-free in 
0.1% gelatine-coated (Sigma) dishes. They were grown 
in Knock Out Serum DMEM (Gibco) supplemented 
with 15% KSR (Gibco), 1% sodium pyruvate (Sigma), 1% 
non-essential amino acids (Sigma), 1% penicillin–strep-
tomycin (Sigma), 1% l-Glutamine (Sigma) and 0.07% 
β-mercaptoethanol (Sigma). The LIF + 2i condition was 
as follows: 1000 U/ml leukaemia inhibitory factor (LIF) 
(Sigma), 10  mM PD0325901 (Stemgent) and 30  mM 
CHIR99021 (StemCell). For all conditions, cells were pas-
saged at 48-h intervals using trypsin (TrypLE Express 
Enzyme 1x, ThermoFisher) for detachment. The Oct4-
GFP positive mESCs were used as an internal control of 
stemness to prevent cell differentiation. For chronic mor-
phine treatment, mESCs were grown in their respective 
medium supplemented with %0.9 (p/v) NaCl and 10 µM 
morphine (Alcaliber) for 24 h for the control and treat-
ment [21] conditions, respectively, and collected for 
further experimentation (P1). After treatment removal, 
mESCs were seeded and maintained in culture for 48 h 
and 96  h and collected (P2 and P3, respectively) for 
experimentation.
Western Blotting
Cells were collected and whole cell extracts (50,000 
cells) were diluted in 4× loading sample buffer contain-
ing dithiothreitol (DTT) (%10v/v) and boiled for 10 min 
at 95  °C. Samples were loaded onto 12% resolving gels 
and separated by one-dimensional sodium dodecyl sul-
phate polyacrylamide gel electrophoresis (SDS-PAGE). 
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Proteins were transferred to polyvinylidene fluoride 
(PVDF) membranes (Amersham Hybond, Sigma) using 
the Mini Trans-Blot electrophoretic transfer system (Bio-
Rad Laboratories, Hercules, CA, USA). Then, the mem-
branes were blocked with Blotto (20 mM Tris–HCl, pH 
7.5, 0.15  M NaCl and 1% Triton X-100) containing 5% 
bovine serum albumin (BSA) for 1 h and then incubated 
with a 1:1000 dilution of a polyclonal rabbit anti-trime-
thyl-histone H3K27 antibody (A2363, Abclonal) over-
night at 4 °C. After washing (3 × 5 min) in Blotto buffer, 
the membranes were incubated for 1 h at RT with perox-
idase-conjugated goat anti-rabbit antibody (Blotto + %5 
BSA 1:1000) (Goat anti-rabbit IgG HRP, sc-2004; Santa 
Cruz Biotechnology). After washing (3 × 5 min), the per-
oxidase activity of the blots was revealed by enhanced 
chemiluminescence (ChemiDoc XRS detector, Bio-Rad). 
The monoclonal mouse anti-beta actin peroxidase anti-
body (A3854, Sigma, 1:25,000) was used for normaliza-
tion. The results were analysed by semi-quantitative 
Western blot densitometry analysis using the ImageJ 
software (image processing and analysis in Java).
Chip‑sequencing
Treated and non-treated mESCs were cross-linked with 
acetone at room temperature for 10  min. Then, to gen-
erate 150–400  bp chromatin fragments, chromatin was 
extracted in chromatin cleaning buffer and sonicated 
(Soniprep 150) in sonication buffer supplemented with 
1% Triton X-100 and a protease and phosphatase inhibi-
tor mixture. Chromatin fragments were diluted two-fold 
with dilution buffer supplemented with 5% glycerol and 
incubated with 30 µl of Dynabeads (Invitrogen) and rab-
bit monoclonal H3K27me3 antibody (4  µg, Millipore, 
REF: 07,449) complex overnight at 4 °C. In parallel assays, 
non-specific rabbit IgG was used as a negative control. 
The beads were washed 2 times with LiCl wash buffer 
(250 mM LiCl, 10 mM Tris–HCl, 1 mM EDTA, pH 8.1, 
1% NP40 and %1 Na deoxycholate) and 2 times with TE 
buffer. The elution was performed twice with 50  µl elu-
tion buffer (100  mM NaHCO3 and 1% SDS, pH 10.1). 
Precipitated DNA was reverse cross-linked at 55 °C over-
night and treated with RNase A and proteinase K. The 
DNA was purified using Agentcourt AMPure XP mag-
netic beads (Beckman Coulter). Prior to library prepara-
tion, pull-down specificity was confirmed by ChIP-qPCR 
using the Homeobox (Hox) region and Tata Binding Site 
(Tbp) genes as positive and negative controls, respec-
tively. DNA fragments were subjected to library construc-
tion using a SMART Low Input Library Preparation Kit. 
After library preparation, the samples were 4× multiplex 
sequenced on an Illumina Hi-Seq 2500 sequencer with 
a minimum of 50 million reads per replicate. The qual-
ity of the reads (with a minimum of 50 million reads per 
replicate) was verified using FASTQC analysis, and good 
overall alignment rate was confirmed for H3K27me3. 
Spearman correlation confirmed the reproducibility of 
the two biological replicates in the H3K27me3 samples, 
and only the binding sites present in both duplicates of 
each sample were considered for further analyses.
RNA‑sequencing
Total RNA from duplicate samples of control and mor-
phine-treated mESCs was isolated using the Trizol rea-
gent (Thermo Fisher) according to the manufacturer’s 
instructions. Sample concentrations and RNA integrity 
number (RIN) quality were measured using the Agilent 
2100 Bioanalyzer system (Agilent Technologies); the RIN 
values indicated high-quality total RNA in all the sam-
ples (RIN > 7). Then, poly(A) RNA samples were purified 
using a Dynabeads mRNA DIRECT Micro Kit (Invitro-
gen). Purified RNAs were subjected to library construc-
tion using a TruSeq stranded mRNA Library Preparation 
Kit (Illumina), and 4× multiple sequencing was per-
formed on an Illumina Hi-Seq 2500 sequencer with a 
minimum of 50 million reads for each of the two repli-
cates per sample.
Bioinformatic analyses
A FastQC High Throughput Sequence QC Report was 
used to assess the quality of the FASTQ files from the 
Chip-Seq and RNA-Seq, showing a quality score greater 
than 30. ChIP sequences were mapped to the UCSC 
mm10 reference genome using Bowtie2, and the result-
ant binary equivalent files were sorted and indexed for 
quicker access using SAMtools. To evaluate the effect of 
morphine on histone distribution, histone binding site 
(BS) identification and annotation was performed using 
MACS as follows: 10.30 m-fold, 300 bandwidth and a p 
value cut-off of  10−5 settings with the aim of calling high-
confidence binding sites. Then, the DiffBind package in 
the R statistical environment was used to identify the 
DBSs between the control and morphine-treated sam-
ples. The binding sites and DBSs were first annotated 
within 1 kb up/downstream of the nearest TSS with the 
R package Chipseeker. The read count data were normal-
ized with TMM normalization to account for library size 
from the binding site identification, and regions were 
with a p value ≤ 0.05 and FDR value ≤ 0.05 were consid-
ered differentially enriched.
The RNA sequences were mapped to the UCSC mm10 
reference genome using Hisat2, a splicing aligner for 
RNA sequencing data. The resultant binary equivalent 
files were sorted and indexed for quicker access using 
SAMtools. Transcript assembly and the number of reads 
per gene were annotated using StringTie with a refer-
ence gene annotation file from the UCSC table browser 
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(mm10). The transcript read count was quantified using 
the feature Counts software from the Subread package in 
the R statistical environment. DEGs between the control 
and morphine-treated samples were identified with the 
edgeR package in the R statistical environment using read 
count data; it utilizes the negative binomial distribution 
to assess statistical significance. The read count data were 
normalized with TMM normalization to account for 
library size. DEGs were defined as all genes with a mul-
tiple testing corrected adjusted p value of ≤ 0.05 and FDR 
value of ≤ 0.05.
Integrative analyses were performed using Venny tools, 
and The Gene Ontology Resource from the GO Consor-
tium (https ://geneo ntolo gy.org/) was used to identify the 
biological functions.
Real‑time PCR (RT‑qPCR)
The total RNAs from mESCs were extracted with the 
Trizol reagent (Thermo Fisher) according to the manu-
facturer’s instructions. Concentrations of RNA were 
determined by measuring absorbance at 260 nm. Purity 
was assessed by the 260/280 nm absorbance ratio. Sam-
ples were reverse transcribed using the iScript cDNA 
synthesis Kit (Invitrogen). Real-time PCR analysis was 
performed using iTaq Universal SYBR Green SuperMix 
(Applied Biosystems, California USA) on an ABI Prism 
7000 Sequence Detection System. The PCR profile was as 
follows: 39 cycles at 95 °C for 10 min (denaturation), 20 
segs at 95 °C (hybridization) and 1 min at 59 °C (anneal-
ing and extension). PCR amplification was repeated by 
more than three independent experiments in triplicates. 
The relative fold induction was quantified by the ddCT 
method. The most stable reference genes, glyceraldehyde 
3-phosphate dehydrogenase (Gapdh) and pyruvate car-
boxylase (Pcx), were used as housekeeping genes for data 
normalization. The primer sequences were as follows: 
Gapdh, forward (F) 5′-TAT GAC TCC ACT CAC GGC 
AAATT-3′ and reverse (R) 5′-TCG CTC CTG GAA GAT 
GGT GAT-3′; Pcx, forward (F) 5′-CAA CAC CTA CGG 
CTT CCC TA-3′, reverse (R) and 5′-CCA CAA ACA ACG 
CTC CAT -3′; Suz12 (polycomb repressive complex 2 Sub-
unit), forward (F) 5′-ACA GAA GCC AGA GAC GAC CT-3′ 
and reverse (R) 5′-GGA GCC ATC ATA ACA CTC ATTG-
3′; Ezh2 (Enhancer Of zeste 2 polycomb repressive com-
plex 2 subunit), forward (F) 5′-AGA ATG TGG AGT GGA 
GTG GTG-3′ and reverse (R) 5′-CAG TGG GAA CAG 
GTG CTA TG-3′; and Eed (Embryonic ectoderm develop-
ment), forward (F) 5′-CCA CAA ATA CGC CAA ATG C-3′ 
and reverse (R) 5′-CAA ACA CCA GAG GGT CTC CT-3′.
ChIP‑qPCR
Following chromatin immunoprecipitation and pos-
terior sequencing data analysis, the obtained results 
were validated by ChIP-qPCR. The levels of DNA in 
the input and the immunoprecipitates were detected 
by quantitative PCR and normalized to the inputs. 
The ChIP primers were as follows: Suz12, forward (F) 
5′-GTG AAG AAG CCG AAA ATG GA-3′ and reverse (R) 
5′-TCC CAA AGC AAG TGG ACT CT-3′; Ezh2, forward 
(F) 5′-CAT AGC CAA CAC AAA AAT AAT CAC A-3′ and 
reverse (R) 5′-AAT AGG GAT AGA AAA AGC CAC TTG 
-3′; and Eed, forward (F) 5′-CTG TTC CCT CCT TTG 
CCT TA-3′ and reverse (R) 5′-CGG TTA TGT ATG CCC 
CTT TC-3′.
Prior to library preparation, pull-down specificity was 
confirmed by ChIP-RT-qPCR. The Homeobox (Hox) 
region and Tata Binding Site (Tbp) genes were used as 
controls to measure the enrichment of histone modifica-
tions, showing enrichment of silenced and active regions 
in the genome, respectively. The primers for H3K27me3 
ChIP specificity were as follows: Hox, forward (F) 5′- 
GAG CTG GCC CTT GGG AAT ATG -3′ and reverse (R) 
5′- GCC AGG AGT CAG TGC CTG AC -3′ and Tbp, for-
ward (F) 5′- TGC AGT CAA GAG CGC AAC TG -3′ and 
reverse (R) 5′- CAC CGC TAC CGG ACT CGA T -3′.
Supplementary information
Supplementary information accompanies this paper at https ://doi.
org/10.1186/s1314 8‑020‑00955 ‑w.
Additional file 1. Supplementary material.
Abbreviations
BSs: Binding sites; CGIs: CpG islands; ChIP‑qPCR: Chromatin immunoprecipita‑
tion quantitative polymerase chain reaction; ChIP‑Seq: Chromatin immuno‑
precipitation sequencing; DBSs: Differential binding sites; DEGs: Differentially 
expressed genes; EED: Embryonic ectoderm development; EZH2: Enhancer 
of zeste homolog 2; FDR: Fold discovery rate; GFP: Green fluorescent protein; 
H3K27me3: Trimethylation at lysine 27 of histone H3; HOX: Homeobox; 
KDM2B: Lysine (K)‑specific demethylase 2B; mESCs:: Mouse embryonic stem 
cells; Oct4: Octamer binding protein 4; PCR: Polymerase chain reaction; PRC2: 
Polycomb repressive complex; RBBP4/RBBP7: Retinoblastoma binding protein 
4 and 7; Ring1b: Ring finger protein 1 b; SET domain: SET nuclear oncogene 
domain; SUZ12: Suz12 polycomb repressive complex 2 subunit; TBP: TATA box 
binding protein; THC: Δ9‑Tetrahydrocannabinol; TSS: Transcription start sites.
Acknowledgements
The authors particularly acknowledge SGIker resources of UPV/EHU for techni‑
cal support with the computational calculations, which were carried out in the 
Arina informatic cluster.
Authors’ contributions
IMH, MA, IUA and MG carried out the experiments and generated data. 
IMH performed the bioinformatic analysis. NS designed the study. NS and 
IMH discussed the data and wrote the manuscript. IG, JAH, CW, PG and BT 
provided conceptual support, contributed to the discussion and reviewed the 
manuscript. The authors read and approved the final manuscript.
Funding
This study was supported by grants from the Spanish Health Department 
ISCIII (DTS 18/00142) and University of the Basque Country. IM was supported 
by fellowship from Basque Government, and MA and IU were supported by 
fellowship from the University of the Basque Country (UPV/EHU).
Page 12 of 13Muñoa‑Hoyos et al. Clin Epigenet          (2020) 12:170 
Availability of data and material
Authors consent to the availability of data and materials. The raw data have 
been deposited in NCBI Sequence Read Archive (SRA) through the Gene 
Expression Omnibus (GEO, Accession Number GSE151234).
Ethics approval and consent to participate
Not applicable.
Consent for publication
All the authors approved the manuscript and consented for publication.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Department of Physiology, Faculty of Medicine and Nursing, University 
of the Basque Country (UPV/EHU), 48940 Leioa, Bizkaia, Spain. 2 Innovation 
in Assisted Reproduction Group, Bizkaia Health Research Institute, 48903 
Barakaldo, Bizkaia, Spain. 3 Chromatin and Gene Expression Group, Institute 
of Cancer and Genomic Sciences, College of Medical and Dental Sciences, 
University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. 4 Stem Cell 
Laboratory, Institute of Cancer and Genomic Sciences, College of Medical 
and Dental Sciences, University of Birmingham, Birmingham, UK. 5 Biodonostia 
Health Research Institute, 2009 San Sebastian, Gipuzkoa, Spain. 
Received: 25 May 2020   Accepted: 21 October 2020
References
 1. de Gonzalo‑Calvo D, Iglesias‑Gutierrez E, Llorente‑Cortes V. Epigenetic 
biomarkers and cardiovascular disease: circulating microRNAs. Rev Esp 
Cardiol (Engl Ed). 2017;70(9):763–9.
 2. Moosavi A, Ardekani AM. Role of epigenetics in biology and human 
diseases. Iran Biomed J. 2016;20(5):246–58.
 3. Ko EB, Hwang KA, Choi KC. Prenatal toxicity of the environmental pol‑
lutants on neuronal and cardiac development derived from embryonic 
stem cells. Reprod Toxicol. 2019;90:15–23.
 4. Kazemi M, Sahraei H, Azarnia M, Dehghani L, Bahadoran H, Tekieh E. The 
effect of morphine consumption on plasma corticosteron concentra‑
tion and placenta development in pregnant rats. Iran J Reprod Med. 
2011;9(2):71–6.
 5. Levitt P. Prenatal effects of drugs of abuse on brain development. Drug 
Alcohol Depend. 1998;51(1–2):109–25.
 6. Nakatani T. Opioid therapy and management of side effects associated 
with opioids. Gan To Kagaku Ryoho. 2017;44(4):294–7.
 7. Eriksson PS, Ronnback L. Effects of prenatal morphine treatment of rats 
on mortality, bodyweight and analgesic response in the offspring. Drug 
Alcohol Depend. 1989;24(3):187–94.
 8. Niknam NA, Azarnia M, Bahadoran H, Kazemi M, Tekieh E, Ranjbaran M, 
Sahraei H. Evaluating the effects of oral morphine on embryonic devel‑
opment of cerebellum in wistar rats. Basic Clin Neurosci. 2013;4(2):130–5.
 9. Gapp K, Jawaid A, Sarkies P, Bohacek J, Pelczar P, Prados J, Farinelli L, Miska 
E, Mansuy IM. Implication of sperm RNAs in transgenerational inheritance 
of the effects of early trauma in mice. Nat Neurosci. 2014;17(5):667–9.
 10. Byrnes JJ, Babb JA, Scanlan VF, Byrnes EM. Adolescent opioid exposure in 
female rats: transgenerational effects on morphine analgesia and anxiety‑
like behavior in adult offspring. Behav Brain Res. 2011;218(1):200–5.
 11. Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in 
life. Nature. 2011;469(7330):343–9.
 12. Cao R, Wang L, Wang H, Xia L, Erdjument‑Bromage H, Tempst P, Jones RS, 
Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb‑group 
silencing. Science. 2002;298(5595):1039–43.
 13. Margueron R, Justin N, Ohno K, Sharpe ML, Son J, Drury WJ, Voigt P, 
Martin SR, Taylor WR, De Marco V, Pirrotta V, Reinberg D, Gamblin SJ. Role 
of the polycomb protein EED in the propagation of repressive histone 
marks. Nature. 2009;461(7265):762–7.
 14. Yuan W, Wu T, Fu H, Dai C, Wu H, Liu N, Li X, Xu M, Zhang Z, Niu T, Han 
Z, Chai J, Zhou XJ, Gao S, Zhu B. Dense chromatin activates Polycomb 
repressive complex 2 to regulate H3 lysine 27 methylation. Science. 
2012;337(6097):971–5.
 15. Hammoud SS, Nix DA, Zhang H, Purwar J, Carrell DT, Cairns BR. Distinctive 
chromatin in human sperm packages genes for embryo development. 
Nature. 2009;460(7254):473–8.
 16. Vastenhouw NL, Schier AF. Bivalent histone modifications in early 
embryogenesis. Curr Opin Cell Biol. 2012;24(3):374–86.
 17. Miao X, Sun T, Barletta H, Mager J, Cui W. Loss of RBBP4 results in defective 
inner cell mass, severe apoptosis, hyperacetylated histones and preim‑
plantation lethality in micedagger. Biol Reprod. 2020;103(1):13–23.
 18. Brykczynska U, Hisano M, Erkek S, Ramos L, Oakeley EJ, Roloff TC, Beisel 
C, Schubeler D, Stadler MB, Peters AH. Repressive and active histone 
methylation mark distinct promoters in human and mouse spermatozoa. 
Nat Struct Mol Biol. 2010;17(6):679–87.
 19. Erkek S, Hisano M, Liang CY, Gill M, Murr R, Dieker J, Schubeler D, van der 
Vlag J, Stadler MB, Peters AH. Molecular determinants of nucleosome 
retention at CpG‑rich sequences in mouse spermatozoa. Nat Struct Mol 
Biol. 2013;20(7):868–75.
 20. Hammoud SS, Low DH, Yi C, Carrell DT, Guccione E, Cairns BR. Chromatin 
and transcription transitions of mammalian adult germline stem cells and 
spermatogenesis. Cell Stem Cell. 2014;15(2):239–53.
 21. Yang H, Sun J, Chen H, Wang F, Li Y, Wang H, Qu T. Mesenchymal stem 
cells from bone marrow attenuated the chronic morphine‑induced 
cAMP accumulation in vitro. Neurosci Lett. 2019;698:76–80.
 22. Li H, Liefke R, Jiang J, Kurland JV, Tian W, Deng P, Zhang W, He Q, Patel DJ, 
Bulyk ML, Shi Y, Wang Z. Polycomb‑like proteins link the PRC2 complex to 
CpG islands. Nature. 2017;549(7671):287–91.
 23. Riising EM, Comet I, Leblanc B, Wu X, Johansen JV, Helin K. Gene silencing 
triggers polycomb repressive complex 2 recruitment to CpG islands 
genome wide. Mol Cell. 2014;55(3):347–60.
 24. Morey L, Santanach A, Di Croce L. Pluripotency and epigenetic fac‑
tors in mouse embryonic stem cell fate regulation. Mol Cell Biol. 
2015;35(16):2716–28.
 25. Chater‑Diehl EJ, Laufer BI, Castellani CA, Alberry BL, Singh SM. Alteration 
of gene expression, dna methylation, and histone methylation in free 
radical scavenging networks in adult mouse hippocampus following fetal 
alcohol exposure. PLoS ONE. 2016;11(5):e0154836.
 26. Veazey KJ, Carnahan MN, Muller D, Miranda RC, Golding MC. Alcohol‑
induced epigenetic alterations to developmentally crucial genes 
regulating neural stemness and differentiation. Alcohol Clin Exp Res. 
2013;37(7):1111–22.
 27. Dholakiya SL, Aliberti A, Barile FA. Morphine sulfate concomitantly 
decreases neuronal differentiation and opioid receptor expression in 
mouse embryonic stem cells. Toxicol Lett. 2016;247:45–55.
 28. Hahn JW, Jagwani S, Kim E, Rendell VR, He J, Ezerskiy LA, Wesselschmidt R, 
Coscia CJ, Belcheva MM. Mu and kappa opioids modulate mouse embry‑
onic stem cell‑derived neural progenitor differentiation via MAP kinases. J 
Neurochem. 2010;112(6):1431–41.
 29. Holliday R. Epigenetics: a historical overview. Epigenetics. 
2006;1(2):76–80.
 30. Pauler FM, Sloane MA, Huang R, Regha K, Koerner MV, Tamir I, Sommer 
A, Aszodi A, Jenuwein T, Barlow DP. H3K27me3 forms BLOCs over silent 
genes and intergenic regions and specifies a histone banding pattern on 
a mouse autosomal chromosome. Genome Res. 2009;19(2):221–33.
 31. Vieux‑Rochas M, Fabre PJ, Leleu M, Duboule D, Noordermeer D. Clustering 
of mammalian Hox genes with other H3K27me3 targets within an active 
nuclear domain. Proc Natl Acad Sci USA. 2015;112(15):4672–7.
 32. Trivedi M, Shah J, Hodgson N, Byun HM, Deth R. Morphine induces redox‑
based changes in global DNA methylation and retrotransposon transcrip‑
tion by inhibition of excitatory amino acid transporter type 3‑mediated 
cysteine uptake. Mol Pharmacol. 2014;85(5):747–57.
 33. Trivedi M, Zhang Y, Lopez‑Toledano M, Clarke A, Deth R. Differential 
neurogenic effects of casein‑derived opioid peptides on neuronal stem 
cells: implications for redox‑based epigenetic changes. J Nutr Biochem. 
2016;37:39–46.
 34. Pan G, Tian S, Nie J, Yang C, Ruotti V, Wei H, Jonsdottir GA, Stewart 
R, Thomson JA. Whole‑genome analysis of histone H3 lysine 4 and 
lysine 27 methylation in human embryonic stem cells. Cell Stem Cell. 
2007;1(3):299–312.
 35. Young MD, Willson TA, Wakefield MJ, Trounson E, Hilton DJ, Blewitt ME, 
Oshlack A, Majewski IJ. ChIP‑seq analysis reveals distinct H3K27me3 
Page 13 of 13Muñoa‑Hoyos et al. Clin Epigenet          (2020) 12:170  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
profiles that correlate with transcriptional activity. Nucleic Acids Res. 
2011;39(17):7415–27.
 36. Schwartz YB, Pirrotta V. Polycomb silencing mechanisms and the man‑
agement of genomic programmes. Nat Rev Genet. 2007;8(1):9–22.
 37. Blackledge NP, Rose NR, Klose RJ. Targeting Polycomb systems to regulate 
gene expression: modifications to a complex story. Nat Rev Mol Cell Biol. 
2015;16(11):643–9.
 38. Hu S, Sheng WS, Lokensgard JR, Peterson PK. Morphine induces 
apoptosis of human microglia and neurons. Neuropharmacology. 
2002;42(6):829–36.
 39. Nasiraei‑Moghadam S, Sahraei H, Bahadoran H, Sadooghi M, Salimi SH, 
Kaka GR, Imani H, Mahdavi‑Nasab H, Dashtnavard H. Effects of maternal 
oral morphine consumption on neural tube development in Wistar rats. 
Brain Res Dev Brain Res. 2005;159(1):12–7.
 40. Eisch AJ, Barrot M, Schad CA, Self DW, Nestler EJ. Opiates inhibit 
neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci USA. 
2000;97(13):7579–84.
 41. Kouzarides T. Chromatin modifications and their function. Cell. 
2007;128(4):693–705.
 42. Matoba S, Wang H, Jiang L, Lu F, Iwabuchi KA, Wu X, Inoue K, Yang L, 
Press W, Lee JT, Ogura A, Shen L, Zhang Y. Loss of H3K27me3 imprint‑
ing in somatic cell nuclear transfer embryos disrupts post‑implantation 
development. Cell Stem Cell. 2018;23(3):343‑354.e5.
 43. Vallot C, Ouimette JF, Rougeulle C. Establishment of X chromosome inac‑
tivation and epigenomic features of the inactive X depend on cellular 
contexts. BioEssays. 2016;38(9):869–80.
 44. Zheng H, Huang B, Zhang B, Xiang Y, Du Z, Xu Q, Li Y, Wang Q, Ma J, 
Peng X, Xu F, Xie W. Resetting epigenetic memory by reprogramming of 
histone modifications in mammals. Mol Cell. 2016;63(6):1066–79.
 45. Henriquez B, Bustos FJ, Aguilar R, Becerra A, Simon F, Montecino M, 
van Zundert B. Ezh1 and Ezh2 differentially regulate PSD‑95 gene 
transcription in developing hippocampal neurons. Mol Cell Neurosci. 
2013;57:130–43.
 46. Akizu N, Estaras C, Guerrero L, Marti E, Martinez‑Balbas MA. H3K27me3 
regulates BMP activity in developing spinal cord. Development. 
2010;137(17):2915–25.
 47. Hojfeldt JW, Laugesen A, Willumsen BM, Damhofer H, Hedehus L, Tvardo‑
vskiy A, Mohammad F, Jensen ON, Helin K. Accurate H3K27 methylation 
can be established de novo by SUZ12‑directed PRC2. Nat Struct Mol Biol. 
2018;25(3):225–32.
 48. Inoue A, Jiang L, Lu F, Zhang Y. Genomic imprinting of Xist by maternal 
H3K27me3. Genes Dev. 2017;31(19):1927–32.
 49. Kim KH, Roberts CW. Targeting EZH2 in cancer. Nat Med. 
2016;22(2):128–34.
 50. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar‑Sinha C, 
Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan 
AM. The polycomb group protein EZH2 is involved in progression of 
prostate cancer. Nature. 2002;419(6907):624–9.
 51. Surface LE, Thornton SR, Boyer LA. Polycomb group proteins set the stage 
for early lineage commitment. Cell Stem Cell. 2010;7(3):288–98.
 52. Karanikolas BD, Figueiredo ML, Wu L. Polycomb group protein enhancer 
of zeste 2 is an oncogene that promotes the neoplastic transformation of 
a benign prostatic epithelial cell line. Mol Cancer Res. 2009;7(9):1456–65.
 53. Li X, Gonzalez ME, Toy K, Filzen T, Merajver SD, Kleer CG. Targeted overex‑
pression of EZH2 in the mammary gland disrupts ductal morphogenesis 
and causes epithelial hyperplasia. Am J Pathol. 2009;175(3):1246–54.
 54. Van Oosten MJ, Bressan RA, Zhu JK, Bohnert HJ, Chinnusamy V. The role of 
the epigenome in gene expression control and the epimark changes in 
response to the environment. Crit Rev Plant Sci. 2014;33(1):64–87.
 55. Sun H, Maze I, Dietz DM, Scobie KN, Kennedy PJ, Damez‑Werno D, Neve 
RL, Zachariou V, Shen L, Nestler EJ. Morphine epigenomically regulates 
behavior through alterations in histone H3 lysine 9 dimethylation in the 
nucleus accumbens. J Neurosci. 2012;32(48):17454–64.
 56. Waisman A, Sevlever F, Elias Costa M, Cosentino MS, Miriuka SG, Ventura 
AC, Guberman AS. Cell cycle dynamics of mouse embryonic stem cells in 
the ground state and during transition to formative pluripotency. Sci Rep. 
2019;9(1):8051.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
